📰 Amgen News
Page 45 - Amgen News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Amgen. Real-time updates on events, politics, business and more.
May 16, 2024
The U.S. Food and Drug Administration granted accelerated approval to tarlatamab, Amgens targeted immunotherapy for treating adults with advanced small cell lung cancer that has worsened despite...
May 16, 2024
Every weekday, the Investing Club releases the Homestretch; an actionable afternoon update just in time for the last hour of trading.
May 16, 2024
The FDA cleared the Amgen drug, called Imdelltra, as a treatment for patients with advanced small-cell lung cancer.
May 16, 2024
The Food and Drug Administration approved Imdelltra (tarlatamab) for the treatment of patients with advanced small cell lung cancer that progressed on or after a platinum-based chemotherapy.
May 16, 2024
The Dow Jones Industrial Average just topped 40,000 for the first time, the latest pop in a good year for Wall Street.
May 16, 2024
Amgen Inc. won US approval for a new drug to treat a particularly aggressive form of advanced lung cancer, providing a badly needed new option for patients when chemotherapy stops working.
May 16, 2024
The treatment is for patients with small cell lung cancer, which afflicts about 35,000 people in the U.S. a year.
May 16, 2024
/PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced that the U.S. Food and Drug Administration (FDA) has approved IMDELLTRA™ (tarlatamab-dlle) for the...